Laurus Labs receives licence from DRDO to manufacture Covid drug 2DG

2DG has been given emergency approval by the Drugs Controller General of India (DCGI) for use on COVID-19 patients in the country, Laurus Labs said in a regulatory filing.

from Latest News https://ift.tt/3Ak11cA
https://ift.tt/eA8V8J https://ift.tt/2LUVdkd

• Tweet
• Share
• Share
• Share
• Share